Biological Functions of Gasdermins in Cancer: From Molecular Mechanisms to Therapeutic Potential

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Feb 26

PMID 33634141

Citations 13

Authors

Man Wang

Xinzhe Chen

Yuan Zhang

Affiliations

Soon will be listed here.

Abstract

Pyroptosis is a type of lytic programmed cell death triggered by various inflammasomes that sense danger signals. Pyroptosis has recently attracted great attention owing to its contributory role in cancer. Pyroptosis plays an important role in cancer progression by inducing cancer cell death or eliciting anticancer immunity. The participation of gasdermins (GSDMs) in pyroptosis is a noteworthy recent discovery. GSDMs have emerged as a group of pore-forming proteins that serve important roles in innate immunity and are composed of GSDMA-E and Pejvakin (PJVK) in human. The N-terminal domains of GSDMs, expect PJVK, can form pores on the cell membrane and function as effector proteins of pyroptosis. Remarkably, it has been found that GSDMs are abnormally expressed in several forms of cancers. Moreover, GSDMs are involved in cancer cell growth, invasion, metastasis and chemoresistance. Additionally, increasing evidence has indicated an association between GSDMs and clinicopathological features in cancer patients. These findings suggest the feasibility of using GSDMs as prospective biomarkers for cancer diagnosis, therapeutic intervention and prognosis. Here, we review the progress in unveiling the characteristics and biological functions of GSDMs. We also focus on the implication and molecular mechanisms of GSDMs in cancer pathogenesis. Investigating the relationship between GSDMs and cancer biology could assist us to explore new therapeutic avenues for cancer prevention and treatment.

Citing Articles

Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma.

Huang H, Ge J, Lu S, Deng X, Tian Y, Huang H Heliyon. 2025; 11(1):e41213.

PMID: 39807507 PMC: 11728984. DOI: 10.1016/j.heliyon.2024.e41213.

Pterostilbene Induces Pyroptosis in Breast Cancer Cells through Pyruvate Kinase 2/Caspase-8/Gasdermin C Signaling Pathway.

Pan T, Peng L, Dong J, Li L Int J Mol Sci. 2024; 25(19).

PMID: 39408842 PMC: 11476961. DOI: 10.3390/ijms251910509.

A Novel Bioluminescent Biosensor Quantifying Intramolecular Interaction and Levels of Pyroptosis Effector GSDMD.

Kelly T, Bhandari S, Carew M, Rubino R, Nicol C, Yang X Cells. 2024; 13(19.

PMID: 39404370 PMC: 11475789. DOI: 10.3390/cells13191606.

The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.

Xia X, Yin W, Mao J, Liu P, Qin C, Hu J Am J Cancer Res. 2023; 13(4):1240-1258.

PMID: 37168356 PMC: 10164816.

Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It.

Chen C, Ye Q, Wang L, Zhou J, Xiang A, Lin X Cell Death Discov. 2023; 9(1):75.

PMID: 36823153 PMC: 9950129. DOI: 10.1038/s41420-023-01370-9.

References

Chen K, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady C . Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019; 38(10). PMC: 6517827. DOI: 10.15252/embj.2019101638. View

Lin P, Lin H, Kuo C, Yang L . N-terminal functional domain of Gasdermin A3 regulates mitochondrial homeostasis via mitochondrial targeting. J Biomed Sci. 2015; 22:44. PMC: 4477613. DOI: 10.1186/s12929-015-0152-0. View

Yu J, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L . Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell. 2007; 28(2):214-27. PMC: 2719761. DOI: 10.1016/j.molcel.2007.08.029. View

Knodler L, Crowley S, Sham H, Yang H, Wrande M, Ma C . Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe. 2014; 16(2):249-256. PMC: 4157630. DOI: 10.1016/j.chom.2014.07.002. View

Ruhl S, Shkarina K, Demarco B, Heilig R, Santos J, Broz P . ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362(6417):956-960. DOI: 10.1126/science.aar7607. View

Webb M, Miller A, Thompson E . In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin. J Steroid Biochem Mol Biol. 2007; 107(1-2):15-21. PMC: 2695606. DOI: 10.1016/j.jsbmb.2007.02.004. View

Van Laer L, Van Camp G, van Zuijlen D, Green E, Verstreken M, Schatteman I . Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Eur J Hum Genet. 1998; 5(6):397-405. View

Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View

Man S, Ekpenyong A, Tourlomousis P, Achouri S, Cammarota E, Hughes K . Actin polymerization as a key innate immune effector mechanism to control Salmonella infection. Proc Natl Acad Sci U S A. 2014; 111(49):17588-93. PMC: 4267384. DOI: 10.1073/pnas.1419925111. View

10.

Das S, Miller M, Broide D . Chromosome 17q21 Genes ORMDL3 and GSDMB in Asthma and Immune Diseases. Adv Immunol. 2017; 135:1-52. DOI: 10.1016/bs.ai.2017.06.001. View

11.

Tanaka S, Mizushina Y, Kato Y, Tamura M, Shiroishi T . Functional conservation of Gsdma cluster genes specifically duplicated in the mouse genome. G3 (Bethesda). 2013; 3(10):1843-50. PMC: 3789809. DOI: 10.1534/g3.113.007393. View

12.

Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F . DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018; 24(8):1151-1156. PMC: 6082709. DOI: 10.1038/s41591-018-0082-y. View

13.

Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M . Transethnic meta-analysis identifies and as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017; 76(6):1150-1158. PMC: 6733404. DOI: 10.1136/annrheumdis-2016-210645. View

14.

Miao E, Leaf I, Treuting P, Mao D, Dors M, Sarkar A . Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010; 11(12):1136-42. PMC: 3058225. DOI: 10.1038/ni.1960. View

15.

Pawlus M, Wang L, Hu C . STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 2013; 33(13):1670-9. PMC: 3868635. DOI: 10.1038/onc.2013.115. View

16.

Mulvihill E, Sborgi L, Mari S, Pfreundschuh M, Hiller S, Muller D . Mechanism of membrane pore formation by human gasdermin-D. EMBO J. 2018; 37(14). PMC: 6043855. DOI: 10.15252/embj.201798321. View

17.

Kovarova M, Hesker P, Jania L, Nguyen M, Snouwaert J, Xiang Z . NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol. 2012; 189(4):2006-16. PMC: 3635067. DOI: 10.4049/jimmunol.1201065. View

18.

Croes L, Op de Beeck K, Pauwels P, Vanden Berghe W, Peeters M, Fransen E . DFNA5 promoter methylation a marker for breast tumorigenesis. Oncotarget. 2017; 8(19):31948-31958. PMC: 5458261. DOI: 10.18632/oncotarget.16654. View

19.

Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara V . Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020; 369(6511):1633-1637. PMC: 8744141. DOI: 10.1126/science.abb9818. View

20.

Wang Y, Gao W, Shi X, Ding J, Liu W, He H . Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017; 547(7661):99-103. DOI: 10.1038/nature22393. View